{"title":"Individual Botanicals Perform Better than AYUSH-64 Formulation in Suppressing TLR4-Driven Inflammatory Cytokines.","authors":"Manisha Dagar, Kamala Priya, Deepika Kumari, Madhu Dikshit, Ajay Kumar","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Dysregulated activation of macrophages through the Toll-like receptor 4 (TLR4) pathway plays a central role in the pathophysiology of numerous inflammatory diseases. The immunomodulatory potential of AYUSH-64, a polyherbal formulation, has recently gained renewed interest. However, the individual contributions of its constituent botanicals, Alstonia scholaris (AS), Picrorhiza kurroa (PK), Swertia chirata (SC), and Caesalpinia crista (CC), remain poorly characterized.</p><p><strong>Objective: </strong>To evaluate and compare the prophylactic immunomodulatory effects of AYUSH-64 and its individual plant extracts on lipopolysaccharide (LPS)-induced inflammation in THP-1-derived macrophage-like cells.</p><p><strong>Methods: </strong>THP-1 monocytes were differentiated using phorbol 12-myristate 13-acetate (PMA) and subsequently stimulated with LPS (100 ng/mL) to activate TLR4 signaling. Before stimulation, cells were pre-treated with AYUSH-64 or its individual extracts (AS, PK, SC, and CC) at concentrations of 30, 100, and 300 µg/mL. Dexamethasone (30 nM) was used as a positive control. Gene expression of pro-inflammatory and regulatory cytokines (TNF-α, IL-1β, and IL-10) was quantified using qRT-PCR, and cytokine secretion levels via ELISA.</p><p><strong>Results: </strong>All treatments, including AYUSH-64 and the individual botanical extracts, were non-cytotoxic to PMA-differentiated THP-1 cells. AYUSH-64 elicited a moderate suppressive effect on TNF-α and IL-10 at both the transcriptional and protein levels, with minimal impact on IL-1β expression. In contrast, individual extracts specifically SC, PK, and CC, demonstrated more pronounced and selective inhibition of inflammatory markers. Notably, SC and PK significantly reduced IL-10 secretion, achieving effects superior to those of dexamethasone. AS showed strong downregulation of TNF-α and IL-10 gene expression, while CC induced a dose-dependent reduction in IL-10 expression and secretion.</p><p><strong>Conclusion: </strong>Individual components of AYUSH-64, especially SC, PK, and CC, demonstrate stronger and more selective anti-inflammatory effects in vitro. They outperformed AYUSH-64 in reducing IL-10 secretion. Thus, constituent-level evaluation in polyherbal formulations is warranted, though further in vivo and clinical studies are needed to confirm their therapeutic potential.</p><p><strong>Keywords: </strong>AYUSH-64, Alstonia scholaris, Picrorhiza kurroa, Swertia chirata, Caesalpinia crista, toll-like receptor 4, inflammation, macrophage.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative therapies in health and medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Dysregulated activation of macrophages through the Toll-like receptor 4 (TLR4) pathway plays a central role in the pathophysiology of numerous inflammatory diseases. The immunomodulatory potential of AYUSH-64, a polyherbal formulation, has recently gained renewed interest. However, the individual contributions of its constituent botanicals, Alstonia scholaris (AS), Picrorhiza kurroa (PK), Swertia chirata (SC), and Caesalpinia crista (CC), remain poorly characterized.
Objective: To evaluate and compare the prophylactic immunomodulatory effects of AYUSH-64 and its individual plant extracts on lipopolysaccharide (LPS)-induced inflammation in THP-1-derived macrophage-like cells.
Methods: THP-1 monocytes were differentiated using phorbol 12-myristate 13-acetate (PMA) and subsequently stimulated with LPS (100 ng/mL) to activate TLR4 signaling. Before stimulation, cells were pre-treated with AYUSH-64 or its individual extracts (AS, PK, SC, and CC) at concentrations of 30, 100, and 300 µg/mL. Dexamethasone (30 nM) was used as a positive control. Gene expression of pro-inflammatory and regulatory cytokines (TNF-α, IL-1β, and IL-10) was quantified using qRT-PCR, and cytokine secretion levels via ELISA.
Results: All treatments, including AYUSH-64 and the individual botanical extracts, were non-cytotoxic to PMA-differentiated THP-1 cells. AYUSH-64 elicited a moderate suppressive effect on TNF-α and IL-10 at both the transcriptional and protein levels, with minimal impact on IL-1β expression. In contrast, individual extracts specifically SC, PK, and CC, demonstrated more pronounced and selective inhibition of inflammatory markers. Notably, SC and PK significantly reduced IL-10 secretion, achieving effects superior to those of dexamethasone. AS showed strong downregulation of TNF-α and IL-10 gene expression, while CC induced a dose-dependent reduction in IL-10 expression and secretion.
Conclusion: Individual components of AYUSH-64, especially SC, PK, and CC, demonstrate stronger and more selective anti-inflammatory effects in vitro. They outperformed AYUSH-64 in reducing IL-10 secretion. Thus, constituent-level evaluation in polyherbal formulations is warranted, though further in vivo and clinical studies are needed to confirm their therapeutic potential.
期刊介绍：
Launched in 1995, Alternative Therapies in Health and Medicine has a mission to promote the art and science of integrative medicine and a responsibility to improve public health. We strive to maintain the highest standards of ethical medical journalism independent of special interests that is timely, accurate, and a pleasure to read. We publish original, peer-reviewed scientific articles that provide health care providers with continuing education to promote health, prevent illness, and treat disease. Alternative Therapies in Health and Medicine was the first journal in this field to be indexed in the National Library of Medicine. In 2006, 2007, and 2008, ATHM had the highest impact factor ranking of any independently published peer-reviewed CAM journal in the United States—meaning that its research articles were cited more frequently than any other journal’s in the field.
Alternative Therapies in Health and Medicine does not endorse any particular system or method but promotes the evaluation and appropriate use of all effective therapeutic approaches. Each issue contains a variety of disciplined inquiry methods, from case reports to original scientific research to systematic reviews. The editors encourage the integration of evidence-based emerging therapies with conventional medical practices by licensed health care providers in a way that promotes a comprehensive approach to health care that is focused on wellness, prevention, and healing. Alternative Therapies in Health and Medicine hopes to inform all licensed health care practitioners about developments in fields other than their own and to foster an ongoing debate about the scientific, clinical, historical, legal, political, and cultural issues that affect all of health care.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
